5,859 reports of this reaction
2.1% of all SPIRONOLACTONE reports
#7 most reported adverse reaction
HEADACHE is the #7 most commonly reported adverse reaction for SPIRONOLACTONE, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 5,859 FDA adverse event reports linking SPIRONOLACTONE to HEADACHE. This represents approximately 2.1% of all 279,694 adverse event reports for this drug.
SPIRONOLACTONE has an overall safety score of 85 out of 100. Patients taking SPIRONOLACTONE who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is a less commonly reported adverse event for SPIRONOLACTONE, but still significant enough to appear in the safety profile.
In addition to headache, the following adverse reactions have been reported for SPIRONOLACTONE:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 5,859 FDA reports for SPIRONOLACTONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 2.1% of all adverse event reports for SPIRONOLACTONE, making it a notable side effect.
If you experience headache while taking SPIRONOLACTONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.